1398 related articles for article (PubMed ID: 29571291)
21. A Prolonged Outbreak of KPC-3-Producing Enterobacter cloacae and Klebsiella pneumoniae Driven by Multiple Mechanisms of Resistance Transmission at a Large Academic Burn Center.
Kanamori H; Parobek CM; Juliano JJ; van Duin D; Cairns BA; Weber DJ; Rutala WA
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919898
[TBL] [Abstract][Full Text] [Related]
22. Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant
Wang X; Wang Q; Cao B; Sun S; Zhang Y; Gu B; Li B; Liao K; Zhao F; Jin L; Jin C; Yang C; Pei F; Zhang Z; Wang H
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348660
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and Risk Factors of Carbapenem-resistant
Kang JS; Yi J; Ko MK; Lee SO; Lee JE; Kim KH
J Korean Med Sci; 2019 May; 34(18):e140. PubMed ID: 31074254
[TBL] [Abstract][Full Text] [Related]
24. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China.
Zhang X; Qu F; Jia W; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H
Int J Antimicrob Agents; 2021 Feb; 57(2):106262. PubMed ID: 33347990
[TBL] [Abstract][Full Text] [Related]
25. Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?
Davido B; Moussiegt A; Dinh A; Bouchand F; Matt M; Senard O; Deconinck L; Espinasse F; Lawrence C; Fortineau N; Saleh-Mghir A; Caballero S; Escaut L; Salomon J
Antimicrob Resist Infect Control; 2018; 7():100. PubMed ID: 30123500
[TBL] [Abstract][Full Text] [Related]
26. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
[TBL] [Abstract][Full Text] [Related]
27. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
[TBL] [Abstract][Full Text] [Related]
28. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
[TBL] [Abstract][Full Text] [Related]
29. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
Balkan II; Aygün G; Aydın S; Mutcalı SI; Kara Z; Kuşkucu M; Midilli K; Şemen V; Aras S; Yemişen M; Mete B; Özaras R; Saltoğlu N; Tabak F; Öztürk R
Int J Infect Dis; 2014 Sep; 26():51-6. PubMed ID: 24998423
[TBL] [Abstract][Full Text] [Related]
30. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
31. 30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study.
Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
Antimicrob Resist Infect Control; 2017; 6():124. PubMed ID: 29225798
[TBL] [Abstract][Full Text] [Related]
32. Infection in cirrhosis: A prospective study.
Bhattacharya C; Das-Mondal M; Gupta D; Sarkar AK; Kar-Purkayastha S; Konar A
Ann Hepatol; 2019; 18(6):862-868. PubMed ID: 31635968
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.
Alraddadi BM; Saeedi M; Qutub M; Alshukairi A; Hassanien A; Wali G
BMC Infect Dis; 2019 Sep; 19(1):772. PubMed ID: 31484510
[TBL] [Abstract][Full Text] [Related]
34. Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
Hyle EP; Ferraro MJ; Silver M; Lee H; Hooper DC
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1242-9. PubMed ID: 21029005
[TBL] [Abstract][Full Text] [Related]
35. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
[TBL] [Abstract][Full Text] [Related]
36. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
37. EUropean prospective cohort study on
Gutiérrez-Gutiérrez B; Sojo-Dorado J; Bravo-Ferrer J; Cuperus N; de Kraker M; Kostyanev T; Raka L; Daikos G; Feifel J; Folgori L; Pascual A; Goossens H; O'Brien S; Bonten MJ; Rodríguez-Baño J;
BMJ Open; 2017 Apr; 7(4):e015365. PubMed ID: 28373258
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
[TBL] [Abstract][Full Text] [Related]
39. Molecular and clinical characteristics of carbapenem-resistant Enterobacteriaceae isolates collected at a tertiary hospital in northern China.
Wang H; Yan Z; Mu L; Gao XY; Li JY; Hu ZD; Wang JR; Zheng WQ
Trans R Soc Trop Med Hyg; 2023 Jan; 117(1):55-57. PubMed ID: 35751581
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals.
Lodise T; Ye MJ; Zhao Q
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]